SYMBIOTEC PHARMALAB LTD Share Price

SYMBIOTEC PHARMALAB LTD Share Price

NSE: SYMBIOTEC
|
Pharmaceuticals
|
S Cap
₹ 1,155.95
+₹60.85 (5.56%)
1D
Last updated 21 Sep, 2026, 14:54 IST

SYMBIOTEC PHARMALAB LTD Share Price Today

As of 21 Sep 2026, SYMBIOTEC PHARMALAB LTD share price is ₹1,155.95. The stock opened at ₹1,104.70, compared to its previous close of ₹1,095.10. During today's trading session, SYMBIOTEC PHARMALAB LTD share price moved in the range of ₹1,104.70 to ₹1,171.00, with an average price of ₹1,137.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹934.20 and a high of ₹1,193.70. On the performance front, SYMBIOTEC PHARMALAB LTD share price has declined by 0.24% over the last six months and is down 0.24% on a year-on-year basis.

₹1,104.70
5.56% up today
₹1,171.00
1D LOW
1D HIGH

SYMBIOTEC PHARMALAB LTD Returns Calculator

Circuit
L
H
₹876.10
₹1,314.10
52-week
L
H
₹934.20
₹1,193.70

About SYMBIOTEC PHARMALAB LTD

SYMBIOTEC PHARMALAB LTD Share Price
ISIN
INE899I01028
Sector Market Cap
₹ 7,024.80 Cr

SYMBIOTEC PHARMALAB LTD Financial Highlights

  • Revenue: SYMBIOTEC PHARMALAB LTD reported revenue of ₹872.26 crore in FY26 vs ₹755.98 crore in FY25. It showed an increase of 15.38% on a yearly basis.
  • Operating Profit: SYMBIOTEC PHARMALAB LTD reported an operating profit of ₹153.36 crore in FY26 vs ₹146.98 crore in FY25. It showed an increase of 4.34% on a year-on-year basis.
  • Net Profit: SYMBIOTEC PHARMALAB LTD reported a net profit of ₹109.90 crore in FY26 vs ₹96.79 crore in FY25. It showed an increase of 13.54% on a yearly basis.
Know more
Promoters
33.28%
FII
21.08%
Other DII
21.98%
Retail and other
18.12%
Mutual funds
5.54%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Aug 202621.08%
Mkt Cap Cr
0.00
P/E
0.00
P/B
0.00
ROE
11.19%
D/E
0.21
ROCE
12.20%
Div. Yield
0.00%
EPS(TTM)
0.00
Turnover
0.00
EV/EBITDA
0.00
Net Margin
19.27%
Op. Margin
33.18%
ROA
7.01%
Quick Ratio
0.65
Curr. Ratio
1.43
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Symbiotec Pharma outperforming most market indices
Step 3 of 5
Valuation
Fairly Valued
Symbiotec Pharma appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Symbiotec Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,40,398.0036.355.2713.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,664.0085.0214.8415.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,82,738.0084.7621.7325.49%1.6913.85%222.760.70%0.4958.70
Zydus Lifesciences1,15,012.0025.044.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,794.0033.023.2211.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,05,645.0096.8919.9316.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma99,828.1026.902.639.25%0.1911.76%394.820.23%0.3841.58
Lupin98,069.8017.674.3723.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories97,749.4030.712.5711.07%0.1812.54%377.950.68%0.4138.68
Mankind Pharma95,743.9046.305.8711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SYMBIOTEC PHARMALAB LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹869.15₹751.55₹716.25₹566.51
Other Income₹3.11₹4.43₹7.09₹6.46
Total Revenue₹872.26₹755.98₹723.33₹572.97
Total Expenses₹709.90₹608.85₹590.99₹533.63
Profit Before Tax₹153.36₹147.13₹132.35₹39.34
Tax₹43.46₹50.19₹30.93₹14.78
Profit After Tax₹109.90₹96.94₹101.42₹24.56
EPS - Basic₹19.10₹88.50₹91.49₹21.48
EPS - Diluted₹19.00₹88.50₹91.49₹21.48

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹153.36₹146.98₹132.35₹39.34
Income before WC changes₹238.78₹208.87₹172.11₹73.21
Change in Assets-₹34.80₹2.36-₹122.13₹20.10
Change in Liabilities₹32.32-₹129.15₹171.80-₹6.07
Change in WC-₹2.47-₹126.79₹49.67₹14.03
Cash flow from Operations₹174.59₹47.26₹187.50₹69.24
Cash flow from Investing-₹226.93-₹306.52-₹206.41-₹219.99
Cash flow from Financing₹35.99₹278.16₹21.85₹146.14
Total Cash Flow-₹16.35₹18.90₹2.94-₹4.61
Cash (Start of the year)₹26.39₹7.50₹4.55₹9.16
Cash (End of the year)₹10.04₹26.39₹7.50₹4.55

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,295.25₹1,086.79₹786.58₹589.82
Current Assets₹485.54₹492.86₹508.21₹400.17
Total Assets₹1,780.79₹1,579.65₹1,294.79₹989.99
Current Liabilities₹527.57₹472.60₹351.21₹228.07
Net Current Asset-₹42.02₹20.26₹157.00₹172.10
Non-Current Liabilities₹103.64₹292.35₹228.73₹140.48
Equity Capital₹1,149.59₹814.71₹714.84₹621.44
Total Equity & Liabilities₹1,780.79₹1,579.65₹1,294.79₹989.99

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹756.68₹673.61₹563.59₹633.85
Other Income₹32.00₹19.76₹12.37₹5.65
Total Revenue₹788.69₹693.37₹575.96₹639.50
Total Expenses₹592.66₹575.47₹519.16₹556.72
Profit Before Tax₹196.02₹117.90-₹7.78₹82.77
Tax₹50.19₹28.95₹14.88₹21.04
Profit After Tax₹145.83₹88.95-₹22.66₹61.73
EPS - Basic₹133.35₹81.33-₹20.72₹56.45
EPS - Diluted₹133.35₹81.33-₹20.72₹56.45

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹196.02₹117.90-₹7.78₹82.77
Income before WC changes₹225.76₹144.09₹83.38₹105.85
Change in Assets₹36.48-₹106.61₹26.35-₹38.27
Change in Liabilities-₹144.12₹145.07-₹0.56-₹20.63
Change in WC-₹107.64₹38.46₹25.80-₹58.89
Cash flow from Operations₹83.29₹147.46₹93.35₹23.62
Cash flow from Investing-₹291.79-₹80.80-₹132.50-₹33.94
Cash flow from Financing₹224.81-₹62.98₹36.53₹14.73
Total Cash Flow₹16.31₹3.67-₹2.62₹4.41
Cash (Start of the year)₹6.20₹2.53₹5.15₹0.74
Cash (End of the year)₹22.51₹6.20₹2.53₹5.15

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹869.80₹594.93₹528.49₹478.86
Current Assets₹479.23₹498.29₹386.62₹415.62
Total Assets₹1,349.04₹1,093.22₹915.12₹894.48
Current Liabilities₹346.32₹298.66₹214.19₹172.15
Net Current Asset₹132.92₹199.63₹172.43₹243.47
Non-Current Liabilities₹91.93₹33.43₹28.12₹27.15
Equity Capital₹910.79₹761.14₹672.81₹695.18
Total Equity & Liabilities₹1,349.04₹1,093.22₹915.12₹894.48
* All values are in INR Crore
Qty
Bid
2
1155.15
9
1155.1
36
1155.05
53
1155
1
1154.95
Ask
Qty
1155.7
1
1155.75
1
1155.8
6
1155.85
4
1155.9
3
Bid Total: 101
Ask Total: 15
Buy orders: 87%
Sell orders: 13%
Bearish
2
Neutral
3
Bullish
0
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
ATR (14)
63.67
Neutral
STOCH(9,6)
43.04
Neutral
ADX(9)
96.42
Bearish
ROC(12)
-0.24
Bearish
WillR(14)
-38
Neutral
Period
Simple value
Exponential vaue
5D
1079.41
1080.39
10D
1094.08
1052.73
20D
1092.93
0
50D
1092.93
0
100D
1092.93
0
Volume trend — traded volume by day
21 Sep11L
18 Sep10L
17 Sep4L
16 Sep7L
15 Sep13L
Average9L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SYMBIOTEC PHARMALAB LTD Share Price
SYMBIOTEC PHARMALAB LTD
Pharmaceuticals
Add Stock
Add Another

SYMBIOTEC PHARMALAB LTD Share Price FAQs

SYMBIOTEC PHARMALAB LTD share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837